How big is the cystoscope market?

In 2027 the market for cystoscope is worth approximately USD 1.58 billion.

What is the anticipated CAGR of the cystoscope industry?

Cystoscope Market size was worth USD 1.46 billion in 2026 and is expected to grow at a 9.49% CAGR between 2027 and 2036, surpassing USD 3.61 billion by 2036.

How is the shift toward minimally invasive urology influencing cystoscope procurement?

Healthcare providers are upgrading to flexible, high-definition, and digitally enabled cystoscopes that improve workflow efficiency, procedural precision, and patient comfort while supporting seamless movement between diagnosis and intervention.

How is the growing burden of urological disorders affecting demand for advanced cystoscopic systems?

Increasing diagnostic volumes are driving hospitals and urology clinics to replace older equipment with advanced systems offering better imaging, maneuverability, and compatibility with therapeutic accessories, improving procedural capacity and diagnostic efficiency.

Why do hospitals hold the largest share of the cystoscope market?

Hospitals held a 43.08% share in 2026 due to their specialized urology departments, ability to manage complex cases, and integrated clinical support for diagnostic and interventional procedures.

Why is the ambulatory surgical center segment growing the fastest in the cystoscope market?

Ambulatory Surgical Centers are expanding rapidly as providers move suitable urology procedures to outpatient settings that offer efficient scheduling, shorter patient stays, and improved operational throughput.

Why does North America lead the cystoscope market?

North America leads with 40.63% share, supported by mature urology care pathways, widespread endoscopic procedures, and strong replacement demand for advanced visualization systems.

What is driving Asia Pacific growth in the cystoscope market?

Asia Pacific’s 11.31% CAGR reflects expanding urology access, rising diagnostic volumes, and continued hospital investment in endoscopy infrastructure and early detection capabilities.

Who are the major participants shaping the cystoscope landscape?

Leading companies in the cystoscope market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker Corporation (United States), Boston Scientific Corporation (United States), Ambu A/S (Denmark), HOYA Corporation (Japan), Becton, Dickinson and Company (United States), UroViu Corporation (United States), SCHÖLLY Fiberoptic GmbH (Germany), Richard Wolf GmbH (Germany).